Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1982-06-28
1983-02-22
Evans, Joseph E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260429R, A61K 4904, C07F 928, C07F 1300
Patent
active
043748210
ABSTRACT:
A myocardial imaging agent is provided having the structure ##STR1## wherein Q, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 and A are as defined herein. A method for scanning the heart, liver or kidneys employing the above agent is also provided.
REFERENCES:
patent: 3695853 (1972-10-01), Klanberg
patent: 3987157 (1976-10-01), Molinski et al.
patent: 4017596 (1977-04-01), Loberg et al.
J. Nucl. Med., 21 (6): p. P56, (1980).
J. Nucl. Med., 22 (6): p. P51, (1981).
Nature, 1959, pp. 1039-1040.
J. Chem. Soc., (London), 1950, pp. 851-856.
Deutsch, Glavan et al., "Cationic Tc-99m Complexes as Potential Myocardial Imaging Agents", J. Nucl. Med. 22:897-907, 1981.
Deutsch et al., "Heart Imaging with Cationic Complexes of Technetium", Science, 214, Oct. 2, 1981, 85-86.
Glavan Kenneth A.
Kronauge James F.
E. R. Squibb & Sons Inc.
Evans Joseph E.
Levinson Lawrence S.
Rodney Burton
LandOfFree
Myocardial imaging agent and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Myocardial imaging agent and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Myocardial imaging agent and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1373158